Letter to Editor: “Relative Impact of Male Urinary Conditions on Overall Quality of Life”

We read with great interest the article by Vasudevan et al., titled “Relative Impact of Male Urinary Conditions on Overall Quality of Life” [1]. The authors should be commended for conducting a large-scale, registry-based analysis that highlights the physical and psychological burden of male urinary conditions, particularly lower urinary tract symptoms (LUTS) and urinary incontinence. Their findings provide meaningful insight into how these disorders affect quality of life, comparable to other chronic diseases such as cardiovascular disease and diabetes. The study's robust sample size, comprehensive data collection, and focus on patient-centered outcomes are especially admirable, reflecting a thoughtful and clinically relevant approach to men's health research. However, despite these valuable contributions, the study presents several methodological limitations that warrant further discussion. Firstly, the study's reliance on self-administered questionnaires (IPSS, SF-12) introduces potential recall and response bias, as participants' subjective interpretation and memory can distort symptom severity and QoL assessment. Such biases may either inflate or underestimate associations between LUTS and QoL—particularly among individuals with psychological distress, where perception of symptoms can be exaggerated. Similar concerns were raised by Bhatt et al. [2], who noted that self-reported LUTS severity introduces subjectivity and recall error in registry-based QoL data. Secondly, there was an absence of longitudinal follow-up. The study's cross-sectional design, based solely on baseline data, restricts the ability to evaluate causal or temporal relationships between LUTS and QoL. Since these relationships are dynamic, cross-sectional data cannot determine whether poor QoL results from LUTS severity or if reduced well-being exacerbates symptom perception. For example, Lee et al. [3] in a large registry-based HoLEP follow-up study, highlighted that short or single-timepoint assessments “fail to capture symptom evolution and treatment-related changes in QoL.” Thirdly, the lack of Psychosocial and Behavioural Covariates. Despite adjustment for demographic and lifestyle factors, omission of key psychosocial variables such as stress, coping, and social support may have introduced unmeasured confounding, inflating the association between LUTS, depression, and QoL. Vredeveld and Ramaekers demonstrated that psychosocial stressors magnify physical and functional limitations in men with comorbid LUTS, highlighting the importance of incorporating such factors in future analyses [4]. Finally, the absence of treatment type stratification. The analysis grouped all men under watchful waiting or pharmacotherapy without stratifying by specific medications or adherence patterns. Variations in therapeutic effects (e.g., α-blockers vs. 5α-reductase inhibitors) may have confounded the relationship between symptom severity and QoL, introducing treatment heterogeneity bias. Ray et al. highlighted the “necessity of stratified analysis by treatment modality” when assessing QoL outcomes in registry-based BPH studies [5]. To address these issues, future research should integrate objective clinical measures (e.g., bladder diaries, uroflowmetry, and post-void residual assessments) alongside patient-reported outcomes. Longitudinal designs with repeated QoL measurements are also needed to establish trends and evaluate durability of LUTS-related effects. Incorporating validated psychosocial tools such as the PHQ-9 and GAD-7 could further disentangle psychological from physiological influences. Future analyses should include treatment-specific subgroup modelling and control for adherence or medication changes during follow-up. In summary, Vasudevan et al. [1] make a valuable contribution by underscoring the significant impact of male urinary conditions on quality of life. However, addressing methodological issues—particularly in data collection, design, and confounding—would enhance the validity and generalizability of future work. Refining registry methods and incorporating psychosocial, longitudinal, and objective measures will be essential for a more comprehensive understanding of LUTS and their real-world impact on men's health.